That comes amid rising COVID levels nationally and in Idaho. But Idaho’s rising reports of illness aren’t straining hospitals, similar to other national summer surges, Idaho epidemiologist Dr ...

The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...

NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...

Health Canada has authorized Moderna's updated COVID-19 vaccine to roll out in fall immunization campaigns. The new Spikevax ...

Jim Cramer likes Pfizer and recommends buying more stock. Six Flags is struggling, but Cramer likes First Solar and Equity ...

The company reported Health Canada authorized the use of its Spikevax KP.2 shot for those aged six months and older. Last ...

Moderna shares are moving higher on Tuesday after the company announced that Health Canada approved its updated COVID-19 ...

The KP.3 variant of SARS-CoV-2 is dominating in Canada right now, accounting for the majority of the COVID-19 cases in the ...

Moderna said that the Canadian government has approved its updated Covid-19 Spikevax for individuals aged six months and older. The biotechnology company on Tuesday said that Health Canada authorized ...

SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians this fall and winter season.

With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...

Shares of Moderna tumbled early Thursday after the vaccine developer said it was cutting research and development spending.